# OnCo record paper-aaml0531-gemtuzumab-gamis-jco-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aaml0531-gemtuzumab-gamis-jco-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aaml0531-gemtuzumab-gamis-jco-2014" ;
  schema:name "AAML0531: gemtuzumab ozogamicin added to chemotherapy for children and adolescents with acute myeloid leukaemia"@en ;
  schema:description "Adding the CD33-targeted antibody-drug conjugate gemtuzumab ozogamicin to two courses of chemotherapy reduced relapses in childhood acute myeloid leukaemia, most clearly in the high-risk group, and it was later restored to the paediatric label."@en ;
  schema:url <https://onco.cc/key-papers/paper-aaml0531-gemtuzumab-gamis-jco-2014/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2014.55.3628>, <https://pubmed.ncbi.nlm.nih.gov/25092781/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2014.55.3628> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Gamis AS, Alonzo TA, Meshinchi S, et al." ;
  onco:cancers <https://onco.cc/cancers/aml-paediatric/> ;
  onco:drugs <https://onco.cc/drugs/gemtuzumab-ozogamicin/> ;
  onco:trials <https://onco.cc/trials/aaml0531/> ;
  onco:journals <https://onco.cc/journals/jco/> .